{"Gastric": [0, 29, 164], "cancer": [1, 30], "is": [2, 38, 135, 148], "the": [3, 80, 113, 160, 168], "third": [4], "leading": [5], "cause": [6], "of": [7, 13, 55, 67, 72, 82, 115, 170], "cancer-related": [8], "deaths": [9], "worldwide.": [10], "Over": [11], "95%": [12], "gastric": [14, 155], "cancers": [15], "are": [16, 19], "adenocarcinomas,": [17], "which": [18, 125], "typically": [20], "classified": [21], "based": [22], "on": [23, 92, 167], "anatomic": [24], "location": [25], "and": [26, 52, 79, 95, 103], "histologic": [27], "type.": [28], "generally": [31], "carries": [32], "a": [33, 89], "poor": [34], "prognosis": [35], "because": [36], "it": [37], "often": [39], "diagnosed": [40], "at": [41], "an": [42], "advanced": [43, 61, 119], "stage.": [44], "Systemic": [45], "therapy": [46], "can": [47], "provide": [48], "palliation,": [49], "improved": [50], "survival,": [51], "enhanced": [53], "quality": [54], "life": [56], "in": [57, 109], "patients": [58, 116, 139, 152], "with": [59, 117, 140, 153], "locally": [60, 118, 172], "or": [62, 120, 142, 175], "metastatic": [63, 121, 143, 176], "disease.": [64, 122, 177], "The": [65], "implementation": [66], "biomarker": [68], "testing,": [69], "especially": [70], "analysis": [71], "HER2": [73], "status,": [74, 78], "microsatellite": [75], "instability": [76], "(MSI)": [77], "expression": [81], "programmed": [83], "death-ligand": [84], "1": [85], "(PD-L1),": [86], "has": [87], "had": [88], "significant": [90], "impact": [91], "clinical": [93, 110], "practice": [94], "patient": [96], "care.": [97], "Targeted": [98], "therapies": [99], "including": [100], "trastuzumab,": [101], "nivolumab,": [102], "pembrolizumab": [104], "have": [105], "produced": [106], "encouraging": [107], "results": [108], "trials": [111], "for": [112, 137, 150, 163], "treatment": [114], "Palliative": [123], "management,": [124], "may": [126], "include": [127], "systemic": [128], "therapy,": [129], "chemoradiation,": [130], "and/or": [131], "best": [132], "supportive": [133], "care,": [134], "recommended": [136], "all": [138, 151], "unresectable": [141, 171], "cancer.": [144, 156], "Multidisciplinary": [145], "team": [146], "management": [147, 169], "essential": [149], "localized": [154], "This": [157], "selection": [158], "from": [159], "NCCN": [161], "Guidelines": [162], "Cancer": [165], "focuses": [166], "advanced,": [173], "recurrent,": [174]}